基层医疗中慢性肾脏病患者的慢性病管理干预:系统综述与Meta分析
该研究系统检索截至2014年11月的随机对照试验,评估基层医疗提供者使用的教育类和计算机辅助慢性病管理干预对慢性肾脏病患者的疗效。共纳入5项研究(188家诊所、494名医生、42852名患者)。与常规护理相比,计算机辅助干预未提高ACEI/ARB使用可能性(合并OR 1.00,95%CI 0.83-1.21;I²=0.0%);教育相关干预与计算机辅助干预相比亦未提高ACEI/ARB使用可能性(合并OR 1.12,95%CI 0.77-1.64;I²=0.0%)。
要点
- 计算机辅助慢性病管理干预与常规护理相比,未提高CKD患者ACEI/ARB使用可能性(合并OR 1.00,95%CI 0.83-1.21)。
- 教育相关干预与计算机辅助干预相比,未提高ACEI/ARB使用可能性(合并OR 1.12,95%CI 0.77-1.64)。
- 报告方法不一致限制了进一步合并数据;迄今随机试验很少且影响甚微。
核心结论
- 迄今针对基层医疗提供者以改善CKD患者照护为目标的慢性病管理干预随机试验很少,已开展的试验显示影响甚微,提示可能需要其他策略或多方面干预来改善社区CKD患者的照护。
研究设计与样本
- 系统综述与Meta分析,检索Medline、Embase和Cochrane Central数据库(建库至2014年11月),纳入评估针对社区基层医疗提供者的教育类和计算机辅助慢性病管理干预的随机对照试验。
- 共纳入5项研究,涉及188家诊所、494名医生、42852名CKD患者。
- 两项研究比较计算机辅助干预策略与常规护理,两项研究比较教育类干预策略与计算机辅助干预策略,一项研究比较这两种干预策略与常规护理。
- 由两名独立评价者评估纳入研究、质量和提取数据,采用随机效应模型估计合并OR和加权均数差。
主要发现
- 与常规护理相比,计算机辅助慢性病管理干预未提高CKD患者ACEI/ARB使用可能性(合并OR 1.00,95%CI 0.83-1.21;I²=0.0%)。
- 教育相关慢性病管理干预与计算机辅助慢性病管理干预相比,未提高ACEI/ARB使用可能性(合并OR 1.12,95%CI 0.77-1.64;I²=0.0%)。
- 报告方法不一致限制了进一步合并数据。
关键数值与推荐
- 质量指标包括ACEI或ARB使用、蛋白尿测量和血压达标;临床结局包括血压和肾小球滤过率变化。
临床怎么用
- 原文未据此给出推荐。
局限性
- 报告方法不一致限制了进一步合并数据。
- 迄今针对基层医疗提供者以改善CKD患者照护为目标的慢性病管理干预随机试验很少。
- 已开展的试验显示影响甚微。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary care providers manage the majority of patients with chronic kidney disease (CKD), although the most effective chronic disease management (CDM) strategies for these patients are unknown. We assessed the efficacy of CDM interventions used by primary care providers managing patients with CKD. METHODS: The Medline, Embase and Cochrane Central databases were systematically searched (inception to November 2014) for randomized controlled trials (RCTs) assessing education-based and computer-assisted CDM interventions targeting primary care providers managing patients with CKD in the community. The efficacy of CDM interventions was assessed using quality indicators [use of angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB), proteinuria measurement and achievement of blood pressure (BP) targets] and clinical outcomes (change in BP and glomerular filtration rate). Two independent reviewers evaluated studies for inclusion, quality and extracted data. Random effects models were used to estimate pooled odds ratios (ORs) and weighted mean differences for outcomes of interest. RESULTS: Five studies (188 clinics; 494 physicians; 42 852 patients with CKD) were included. Two studies compared computer-assisted intervention strategies with usual care, two studies compared education-based intervention strategies with computer-assisted intervention strategies and one study compared both these intervention strategies with usual care. Compared with usual care, computer-assisted CDM interventions did not increase the likelihood of ACEI/ARB use among patients with CKD {pooled OR 1.00 [95% confidence interval (CI) 0.83-1.21]; I2 = 0.0%}. Similarly, education-related CDM interventions did not increase the likelihood of ACEI/ARB use compared with computer-assisted CDM interventions [pooled OR 1.12 (95% CI 0.77-1.64); I2 = 0.0%]. Inconsistencies in reporting methods limited further pooling of data. CONCLUSIONS: To date, there have been very few randomized trials testing CDM interventions targeting primary care providers with the goal of improving care of people with CKD. Those conducted to date have shown minimal impact, suggesting that other strategies, or multifaceted interventions, may be required to enhance care for patients with CKD in the community.
引用
- Galbraith L, Jacobs C, Hemmelgarn BR, et al. Chronic disease management interventions for people with chronic kidney disease in primary care: a systematic review and meta-analysis. Nephrol Dial Transplant. 2018. PMID: 28096482. doi:10.1093/ndt/gfw359
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。